TY - JOUR T1 - Correction: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer SP - 1 LP - 1 DO - 10.1136/jitc-2021-003000corr1 VL - 9 IS - 9 A2 - , Y1 - 2021/09/01 UR - http://jitc.bmj.com/content/9/9/1.3.abstract ER -